Becker's Healthcare September 16, 2024
As pharmaceutical innovation for oncology care continues to grow, here are four updates to know:
- The market for radiopharmaceuticals has the potential to grow to “tens of billions” if the drugs are proven to be effective.
- AstraZeneca’s bladder cancer drug durvalumab, called Imfinzi, reduced the risk of disease progression and recurrence by 32% and the risk of death by 25% in patients with bladder cancer in a global, clinical trial. ...
Today's Sponsors
Today's Sponsor